Last edition
News about "Jubilant Pharmova Q2 net profit stood at Rs.143 cr"
Jubilant Pharmova Q2 net profit stood at Rs.143 crore
The company's radiopharma business witnessed improvement in sales YoY, however pace of recovery during the quarter was affected by increase in Covid-19 cases in the US, while CMO business revenue grew YoY based on continued strong demand from customers as well as due to Covid related deals
Jubilant Pharmova Q2 Net Profit Stood At Rs.143 Cr | 24/10/2021 | By Darshana | 250
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members